KE

Klaus Erb

AN Ablynx N.V.: 3 patents #59 of 180Top 35%
SA Sanofi: 3 patents #505 of 1,881Top 30%
BO BOE: 2 patents #5,928 of 12,373Top 50%
LG Lurgi Gmbh: 1 patents #44 of 105Top 45%
MA Metallgesellschaft Ag: 1 patents #308 of 715Top 45%
📍 Ingelheim am Rhein, DE: #71 of 330 inventorsTop 25%
Overall (All Time): #605,951 of 4,157,543Top 15%
8
Patents All Time

Issued Patents All Time

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
12384840 Nucleic acids encoding polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLP Heidi Rommelaere, Ann Brigé, Sigrid Cornelis, Bruno Dombrecht, Eric Lorent +4 more 2025-08-12
12171795 Recombinant rhabdovirus encoding for a CD80 extracellular domain Fc-fusion protein Philipp Mueller, Patrik ERLMANN, Guido Wollmann 2024-12-24
11840566 Methods of treating asthma with polypeptides targeting IL-13 and TSLP Heidi Rommelaere, Ann Brigé, Sigrid Cornelis, Bruno Dombrecht, Eric Lorent +4 more 2023-12-12
11707495 Recombinant rhabdovirus encoding for CCL21 Philipp Mueller, Patrik ERLMANN, Tobias Friederike NOLDEN, John Park, Guido Wollmann 2023-07-25
11208476 Polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLP Heidi Rommelaere, Ann Brigé, Sigrid Cornelis, Bruno Dombrecht, Eric Lorent +4 more 2021-12-28
7311837 Process for the continuous recovery of free tartaric acid from raw materials containing potassium hydrogentartrate Dieter Stein, Rudolf Bönsch 2007-12-25
6569436 Method of using a vaccine Graham Le Gros, Charles Richard William Beasley, John William Holloway 2003-05-27
6534678 Process for producing tartaric acid from a raw material containing potassium hydrogentartrate Rudolf Bönsch, Dieter Stein 2003-03-18